Exact Mass: 999.3954040000001

Exact Mass Matches: 999.3954040000001

Found 33 metabolites which its exact mass value is equals to given mass value 999.3954040000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lacto-N-difucopentaose II

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5S)-1,2,5-trihydroxy-6-oxo-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C38H65NO29 (999.364208)


Lacto-N-difucopentaose II is an oligosaccharide first isolated from human milk by recycling chromatography in 1988. Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. (PMID 3274083, 10837303, 11787695, 14530096, 17002410) [HMDB] Lacto-N-difucopentaose II is an oligosaccharide first isolated from human milk by recycling chromatography in 1988. Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. (PMID 3274083, 10837303, 11787695, 14530096, 17002410).

   

Lacto-N-difucohexaose

N-[(2R,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R)-4-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-1-oxo-2-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidate

C38H65NO29 (999.364208)


Lacto-N-difucohexaose (LDFH) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. Calicivirus diarrhea occurs less often in infants whose mothers milk contains high levels of LDFH. (PMID: 15343178, 17375110, 12568665) [HMDB] Lacto-N-difucohexaose (LDFH) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. Calicivirus diarrhea occurs less often in infants whose mothers milk contains high levels of LDFH. (PMID: 15343178, 17375110, 12568665).

   

beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-[alpha-L-Fuc(1->3)]-D-Glcp|lacto-N-difucohexaose II

beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-[alpha-L-Fuc(1->3)]-D-Glcp|lacto-N-difucohexaose II

C38H65NO29 (999.364208)


   

Lacto-N-neo-difucohexaose II

Lacto-N-neo-difucohexaose II

C38H65NO29 (999.364208)


   
   
   
   

Ferrichrome A [M-H2+Fe]

Ferrichrome A [M-H2+Fe]

C41H61N9O20 (999.4032666)


   

LNDFH II

O-6-Deoxy-alpha-L-galactopyranosyl-(1->3)-O-[O-6-deoxy-alpha-L-galactopyranosyl-(1->4)-O-[b-delta-galactopyranosyl-(1->3)]-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-beta-delta-galactopyranosyl-(1->4)]- D-glucose

C38H65NO29 (999.364208)


   

LND I

O-6-Deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

C38H65NO29 (999.364208)


   

ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

C38H65NO29 (999.364208)


   

(Z)-5-[3-[5-[3-[[(E)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-8-[3-[[(Z)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl-hydroxyamino]-3-methyl-5-oxopent-3-enoic acid

(Z)-5-[3-[5-[3-[[(E)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-8-[3-[[(Z)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl-hydroxyamino]-3-methyl-5-oxopent-3-enoic acid

C41H61N9O20 (999.4032666)


   

Lacto-N-difucohexaitol I

Lacto-N-difucohexaitol I

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C38H65NO29 (999.364208)


   

alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp

alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp

C38H65NO29 (999.364208)


   

Gal(a1-3)[Fuc(a1-4)]GlcNAc(b1-4)[Fuc(a1-3)]Gal(b1-4)Glc

Gal(a1-3)[Fuc(a1-4)]GlcNAc(b1-4)[Fuc(a1-3)]Gal(b1-4)Glc

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)a-Man

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)a-Man

C38H65NO29 (999.364208)


   

Fuc(a1-4)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

Fuc(a1-4)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C38H65NO29 (999.364208)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

C38H65NO29 (999.364208)


   

Fuca1-2Galb1-3GalNAca1-3(Fuca1-2)Galb1-4Glcb

Fuca1-2Galb1-3GalNAca1-3(Fuca1-2)Galb1-4Glcb

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)]Gal(b1-4)Glc

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)]Gal(b1-4)Glc

C38H65NO29 (999.364208)


   

Fuc(a1-2)[Gal(a1-3)]Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal

Fuc(a1-2)[Gal(a1-3)]Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal

C38H65NO29 (999.364208)


   

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Man

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Man

C38H65NO29 (999.364208)


   

Lacto-N-difucohexaose

Lacto-N-difucohexaose

C38H65NO29 (999.364208)


   

Lacto-N-difucopentaose II

Lacto-N-difucopentaose II

C38H65NO29 (999.364208)


   

(3s,6r,8r)-15-[(4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,14-trihydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-(1h-indol-3-yl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione

(3s,6r,8r)-15-[(4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,14-trihydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-(1h-indol-3-yl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione

C53H61NO18 (999.3888446000001)


   

(3e)-4-{[3-(17-{3-[(2e)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-14-{3-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-3,6,9,12,15,18-hexahydroxy-5,8-bis(hydroxymethyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl)propyl](hydroxy)carbamoyl}-3-methylbut-3-enoic acid

(3e)-4-{[3-(17-{3-[(2e)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-14-{3-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-3,6,9,12,15,18-hexahydroxy-5,8-bis(hydroxymethyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl)propyl](hydroxy)carbamoyl}-3-methylbut-3-enoic acid

C41H61N9O20 (999.4032666)